QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs and ...

OT spoke to three suppliers about meeting the visual and high-performance needs of patients involved in sports ...

JERUSALEM, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Dror Ortho-Design, Inc. ("Dror" or the "Company") (OTC PINK: DROR), a pioneer in AI-powered orthodontic solutions, today announced a strategic partnership ...

A BUSINESS based inside Warrington Market has won a prestigious award. EDGE Eyewear has been named as Optician of the Year 2024 in the Business Awards UK. As well as winning this award, they were also ...

Welcome to the Align fourth quarter and full-year 2024 earnings call. At this time, all participants are in a listen-only ...

Orthokeratology treatment alters corneal biomechanical properties, and this may predict early myopia control treatment outcomes.

Prior to NeoGenomics, Mr. Smith served as Chairman and CEO of Ortho Clinical Diagnostics which was sold to ... including PacBio's most recent reports on Forms 8-K, 10-K, and 10-Q, and include those ...

Q4 2024 Earnings Call Transcript February 5, 2025 Operator: Greetings. Welcome to the Align Fourth Quarter and Full Year 2024 ...

Myocardial injury after a hip fracture is common and has a poor prognosis. Patients with a hip fracture and myocardial injury ...

Age and myopia severity may best determine whether to initiate highly asperhical lenslets or orthokeratology as a myopia control treatment.

In August, QDEL announced the FDA 510(k) clearance for its VITROS syphilis assay part of its menu, which is likely to strengthen its position as a leader in infectious disease testing. The ...